Advanced Adult Hepatocellular Carcinoma
Oncology
4
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 3 programs with unclassified modality
Competitive Landscape
4 companies ranked by most advanced pipeline stage
M&
Merck & Co.RAHWAY, NJ
1 program1
Dalantercept plus sorafenibPhase 1/2Small Molecule1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CASI PharmaceuticalsENMD-2076
Merck & Co.Dalantercept plus sorafenib
AstraZenecaAZD9150
Clinical Trials (3)
Total enrollment: 58 patients across 3 trials
A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma
Start: Oct 2015Est. completion: Jun 2018
Phase 2Completed
Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Start: Aug 2014Est. completion: Sep 2017
Phase 1/2Completed
A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma
Start: May 2013Est. completion: Feb 201558 patients
Phase 1Completed
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
26m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
26m ago
Office Administrator
SystImmune
26m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
36m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
40m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
40m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space